Welcome to our dedicated page for AI / ML INNOVATIONS news (Ticker: AIMLF), a resource for investors and traders seeking the latest updates and insights on AI / ML INNOVATIONS stock.
AI/ML Innovations Inc. (AIMLF) is a pioneering company in the artificial intelligence (AI) and machine learning (ML) sectors, dedicated to acquiring and advancing technologies that address critical societal needs. Established to capitalize on the burgeoning fields of AI and ML, the company focuses on emerging digital health and wellbeing solutions that leverage AI, cloud computing, and digital platforms to revolutionize healthcare management.
AI/ML Innovations Inc. is committed to transforming healthcare through strategic partnerships and innovative initiatives. Its majority-owned subsidiary, Health Gauge Inc., is at the forefront of health tech innovation. Health Gauge has developed the ‘Follow Your Heart’ smartwatch, a wellness tool that uses proprietary AI PrecisionPulse Neural Network measurement technology to provide non-invasive, medical-grade accurate blood pressure readings. This product is a significant step forward in addressing the hypertension epidemic, offering users convenient and precise health monitoring.
In addition to consumer products, AI/ML Innovations Inc. supports healthcare innovators and researchers with advanced tools like The Pulse Guru, a smart sensor wearable that offers unparalleled access to raw ECG and PPG signal data. This device is instrumental for professionals needing detailed cardiovascular insights.
The company’s strategic growth also includes a recent acquisition of Naiad Labs Inc.’s product division, integrating the Long ECG Neural Net, which drastically reduces the time needed to label long ECGs, enhancing accuracy and efficiency in cardiovascular diagnostics.
AI/ML Innovations Inc. continues to expand its technological footprint with the launch of NeuralCloud Solutions Incorporated, a subsidiary focused on merging smart sensor technology with digital health. The company aims to make high-quality personal biometric data accessible to individuals globally, supported by robust AI and neural network technologies.
AI/ML Innovations Inc. trades on the Canadian Securities Exchange under the symbol AIML, the OTCQB Venture Market under AIMLF, and the Frankfurt Stock Exchange under 42FB. For more information, visit the company's website.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has introduced Health Coach, an AI-powered personal health advisor developed by its subsidiary Health Gauge Inc. This innovative system facilitates users to set personalized health goals and receive tailored care recommendations by analyzing their health data. User trials are set to begin shortly, with a full service subscription version planned for release later this year. Initially, Health Coach will be offered for free to select users, with limited interaction capabilities. Its unique design addresses the 'hallucination problem' seen in other AI systems by ensuring accurate information delivery. Health Coach aims to complement healthcare professionals and has potential for significant disruption in the healthcare industry by leveraging AI technology to enhance patient care.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) announced that its subsidiary, Tech2Heal, will serve as the technology partner for Europe's largest study focused on preventing loss of autonomy in the elderly. The study, led by the University Hospital of Nice, France, will involve 30,000 patients and aims to provide personalized care pathways. Tech2Heal's Alakin Platform will facilitate data collection, patient engagement, and customized clinical trials. With over 100 million Europeans aged 65 or older, this initiative highlights the market potential for innovative healthcare solutions targeting aging populations. CEO Fabrice Pakin emphasizes the promising revenue streams from such projects.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) has announced a marketing services agreement with Frontier Flex Marketing Group to enhance public exposure over 12 months, compensating Frontier $96,000. The company has also issued 1,000,000 stock options to management at an exercise price of $0.20 for five years, pending regulatory approvals. AI/ML Innovations focuses on artificial intelligence and machine learning within digital health, with significant stakes in Health Gauge (100% ownership), Tech2Heal (22% potential ownership), and AI Rx Inc. (70% ownership). The company aims to advance transformative healthcare solutions.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has updated its previous announcement regarding a non-brokered private placement. The Company accepted subscriptions for 4,867,748 units at a price of $0.06 per unit, bringing gross proceeds to $292,064.88, lower than the earlier stated 5,086,498 units. AI/ML continues to focus on investments in artificial intelligence (AI) and machine learning (ML), particularly in digital health and wellbeing sectors. The Company holds strategic partnerships, including a 70% ownership in Health Gauge and AI Rx Inc., which aim to enhance healthcare solutions.
AI/ML Innovations Inc. (CSE:AIML; OTCQB:AIMLF) has successfully closed a non-brokered private placement, raising $305,190.04 by accepting subscriptions for 5,086,498 units priced at $0.06 per unit. Each unit comprises one common share and one common share purchase warrant, allowing the purchase of an additional share at $0.10 for two years, with potential acceleration if shares trade at or above $0.20 for 10 consecutive days. A total of 420,000 units were subscribed by an insider. The funds will be used for general working capital, while the securities are subject to a hold period until July 15, 2023.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) announced that its subsidiary, Health Gauge Inc., completed a successful blood pressure validation study for its wearable device, the Phoenix. This study indicates the device's compliance with regulatory standards for medical devices. The CTO noted the importance of finishing the FDA verification process, which would make Phoenix a Class 2 medical device approved for blood pressure monitoring. The study showcased the effectiveness of Health Gauge's AI technology, revealing minimal mean absolute errors in blood pressure estimations. This milestone supports upcoming FDA and Health Canada submissions, enhancing future business opportunities.
FAQ
What is the current stock price of AI / ML INNOVATIONS (AIMLF)?
What is the market cap of AI / ML INNOVATIONS (AIMLF)?
What does AI/ML Innovations Inc. do?
What is 'Follow Your Heart'?
What are the key features of The Pulse Guru?
What recent acquisitions has AI/ML Innovations Inc. made?
What is NeuralCloud Solutions Incorporated?
How does AI/ML Innovations Inc. plan to expand its market presence?
Where can I buy AI/ML Innovations Inc. products?
What is the Neural Net Store?
How does AI/ML Innovations Inc. support the healthcare industry?